← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mirimus, Inc.
Brooklyn, NY
$4,611,462
Total funding
6
Grants
Funding over time
peak $1M · FY2014–24$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,611,462 · 6
By mechanism
R44$3,440,026 · 2
R43$773,520 · 3
R41$397,916 · 1
Investigators at Mirimus, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
CRISPR/Cas-mediated development of an RNAi rat model system$1,020,397
R44 · FY2020 · OD
CRISPR/Cas-mediated development of an RNAi rat model system$1,011,479
R44 · FY2021 · OD
Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research$751,587
R44 · FY2018 · CA
Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research$656,563
R44 · FY2017 · CA
Preclinical Evaluation of a Novel ADAM10 Modulator to Treat ColorectalCancer$397,916
R41 · FY2023 · CA
Creation of the Next Generation RNAi Therapeutics and an in vivo model for their study$350,000
R43 · FY2024 · GM
High efficiency platform for rapid RNAi rat model development$234,510
R43 · FY2018 · OD
RNA interference - genetically engineered mouse models(RNAi-GEMMs): a novel appro$189,010
R43 · FY2014 · CA